Xuelian Chen (Xiao Chen)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Top Venues

Cancer medicine

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Jia-Yi Huang, Xue-Lian Chen, Xiao-Feng Xie, Lin Song, Li-Ping Chen, Xiao-Feng Lan, Xue Bai, Xuelian Chen, Cai-Wen Du
The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer. Cancer medicine 13 (8) (2024)
Jia-Yi Huang, Xue-Lian Chen, Xiao-Feng Xie, Lin Song, Li-Ping Chen, Xiao-Feng Lan, Xue Bai, Xuelian Chen, Cai-Wen Du
The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer. Cancer medicine 13 (8) (2024)
Jia-Yi Huang, Xue-Lian Chen, Xiao-Feng Xie, Lin Song, Li-Ping Chen, Xiao-Feng Lan, Xue Bai, Xuelian Chen, Cai-Wen Du
The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer. Cancer medicine 13 (8) (2024)
Yimeng Chen, Yin Guan, Jiayu Wang, Zongbi Yi, Yang Luo, Shanshan Chen, Pin Zhang, Qing Li, Ruigang Cai, Qiao Li, Hongnan Mo, Bo Lan, Xuelian Chen, Weihong Zhao, Bing-He Xu, Ying Fan
Platinum-based chemotherapy in advanced triple-negative breast cancer: A multicenter real-world study in China. International journal of cancer 147 (12) (2020)
Jing Huang, Hongnan Mo, Weilong Zhang, Xuelian Chen, Dong Qu, Xi Wang, Dawei Wu, Xingyuan Wang, Bo Lan, Beibei Yang, Pei Wang, Bo Zhang, Qing Yang, Yuchen Jiao, Binghe Xu
Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China. Cancer 125 (5) (2018)